Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Necrotizing pancreatitis after transcatheter arterial chemoembolization for hepatocellular carcinoma.

Ozçinar B, Güven K, Poyanli A, Ozden I.

Diagn Interv Radiol. 2009 Mar;15(1):36-8.

2.

Fatal ischemic acute pancreatitis complicating trans-catheter arterial embolization of small hepatocellular carcinoma: do the risks outweigh the benefits?

Addario L, Di Costanzo GG, Tritto G, Cavaglià E, Angrisani B, Ascione A.

J Hepatol. 2008 Jul;49(1):149-52. doi: 10.1016/j.jhep.2008.02.021.

3.

Acute pancreatitis after embolization of liver tumors: frequency and associated risk factors.

López-Benítez R, Radeleff BA, Barragán-Campos HM, Noeldge G, Grenacher L, Richter GM, Sauer P, Buchler M, Kauffmann G, Hallscheidt PJ.

Pancreatology. 2007;7(1):53-62.

PMID:
17449966
4.

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, Tibballs J, Meyer T, Patch DW, Burroughs AK.

Cardiovasc Intervent Radiol. 2007 Jan-Feb;30(1):6-25. Review.

PMID:
17103105
5.

Diagnosis and management of acute pancreatitis.

Baker S.

Crit Care Resusc. 2004 Mar;6(1):17-27.

PMID:
16563102
6.

Two cases of acute necrotizing pancreatitis complicating after transcatheter arterial embolization for hepatocellular carcinoma.

Komekado H, Kokuryu H, Kimura T, Maruo T, Kita R, Osaki Y, Shintaku M, Sawabu T, Seno H.

J Gastroenterol. 2005 Jan;40(1):107-8. No abstract available.

PMID:
15692799
7.
8.

Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion.

Kim P, Prapong W, Sze DY, So SK, Razavi MK.

Tech Vasc Interv Radiol. 2002 Sep;5(3):127-31.

PMID:
12524643
9.

Hepatocellular carcinoma: an epidemiologic view.

El-Serag HB.

J Clin Gastroenterol. 2002 Nov-Dec;35(5 Suppl 2):S72-8. Review.

PMID:
12394209
10.

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.

Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, Rodés J, Bruix J; Barcelona Liver Cancer Group..

Lancet. 2002 May 18;359(9319):1734-9.

PMID:
12049862
11.

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.

Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J.

Hepatology. 2002 May;35(5):1164-71.

PMID:
11981766
12.

Percutaneous intervention in acute pancreatitis.

Lee MJ, Wittich GR, Mueller PR.

Radiographics. 1998 May-Jun;18(3):711-24; discussion 728. Review. Erratum in: Radiographics 1998 Sep-Oct;18(5):1336.

PMID:
9599393
13.

Complications associated with transcatheter arterial embolization for hepatic tumors.

Sakamoto I, Aso N, Nagaoki K, Matsuoka Y, Uetani M, Ashizawa K, Iwanaga S, Mori M, Morikawa M, Fukuda T, Hayashi K, Matsunaga N.

Radiographics. 1998 May-Jun;18(3):605-19.

PMID:
9599386
14.

Pancreatic tissue damage by transcatheter arterial embolization for hepatoma.

Khan KN, Nakata K, Shima M, Kusumoto Y, Ishii N, Koji T, Nagataki S.

Dig Dis Sci. 1993 Jan;38(1):65-70.

PMID:
7678384
Items per page

Supplemental Content

Support Center